Dalfampridine 00591-2533
Product NDC
00591-2533- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 31, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA206836
Need to source Dalfampridine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dalfampridine | 10 mg/1 |
Drug Class
Potassium Channel Blocker [EPC]Potassium Channel Antagonists [MoA]Potassium Channel Blocker [EPC]
Packaging Options(1)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-2533-60)